Fonte: Revista do instituto de medicina tropical de sao paulo. Unidade: FM
Assuntos: HEPATITE C, HEPATITE VIRAL HUMANA, GENÓTIPOS
ABNT
SANTOS, Ana Paula de Torres et al. Characterization of primary direct-acting antiviral (DAA) drugs resistance mutations in NS5A/NS5B regions of hepatitis C virus with genotype 1a and 1b from patients with chronic hepatitis. Revista do instituto de medicina tropical de sao paulo, v. 64, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50561. Acesso em: 11 nov. 2024.APA
Santos, A. P. de T., Silva, V. C. M., Mendes-Correa, M. C., Lemos, M. F., Malta, F. de M., Santana, R. A. F., et al. (2022). Characterization of primary direct-acting antiviral (DAA) drugs resistance mutations in NS5A/NS5B regions of hepatitis C virus with genotype 1a and 1b from patients with chronic hepatitis. Revista do instituto de medicina tropical de sao paulo, 64. doi:10.1590/S1678-9946202264061NLM
Santos AP de T, Silva VCM, Mendes-Correa MC, Lemos MF, Malta F de M, Santana RAF, Dastoli GTF, Castro VFD de, Pinho JRR, Moreira RC, Correa MCJM. Characterization of primary direct-acting antiviral (DAA) drugs resistance mutations in NS5A/NS5B regions of hepatitis C virus with genotype 1a and 1b from patients with chronic hepatitis [Internet]. Revista do instituto de medicina tropical de sao paulo. 2022 ; 64[citado 2024 nov. 11 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50561Vancouver
Santos AP de T, Silva VCM, Mendes-Correa MC, Lemos MF, Malta F de M, Santana RAF, Dastoli GTF, Castro VFD de, Pinho JRR, Moreira RC, Correa MCJM. Characterization of primary direct-acting antiviral (DAA) drugs resistance mutations in NS5A/NS5B regions of hepatitis C virus with genotype 1a and 1b from patients with chronic hepatitis [Internet]. Revista do instituto de medicina tropical de sao paulo. 2022 ; 64[citado 2024 nov. 11 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50561